EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/959475
EW FEATURE 48 Intersection of refractive surgery and MIGS • April 2018 AT A GLANCE • The benefits of MIGS include eliminating or reducing the need for topical IOP-controlling drops. • Femtosecond technology has not proven highly applicable to the glaucoma space. • Future IOL developments may include their use as IOP telemetry or drug delivery devices. by Rich Daly EyeWorld Contributing Writer glaucoma, but there is also a lifestyle opportunity, so in many cases they may need less drops or no drops at all. That conversation resonates with patients." Benefits of MIGS include eliminating or reducing the need for topical IOP-controlling drops, which can cause chronic issues with long-term use. Chronic conditions include ocular surface disease and cosmetically significant periorbital atrophy of fat and sunken orbits. "There's a convenience factor as well as potential cosmetic consider- ations like the eyes not being as red, and long-term avoidance of some Surgeons share what they think the future holds for refractive surgery and MIGS M icroinvasive glauco- ma surgery (MIGS) is "coming of age" as a lifestyle treatment— similar to refractive lens surgery's earlier evolution. That was the recent assessment of George Waring IV, MD, founder and medical director, Waring Vision Institute, Mt. Pleasant, South Caroli- na, who noted that they are compli- mentary procedures and both have a lifestyle component. "People seek out refractive lens procedures to reduce their need for bifocals and reading glasses," Dr. Waring said. "With MIGS it is not only the opportunity to lower pressure to prevent the worsening of What's coming in refractive surgery and MIGS? The iStent, if properly positioned, is stable and easy to evaluate with a gonio lens postop. Source: Gary Wortz, MD Monthly Pulse Intersection of refractive surgery and MIGS EyeWorld Monthly Pulse is a reader survey on trends and patterns for the practicing ophthal- mologist. Each month we send an online survey covering different topics so readers can see how they compare to our survey. If you would like to join the physicians who take a minute a month to share their views, please send us an email and we will add your name. Email carly@eyeworld. org and put "EW Pulse" in the subject line. If performing a presbyopia-correcting cataract extraction in a patient with mild glaucoma, I would likely choose: Trabecular meshwork bypass stent or removal Supraciliary stenting procedure Subconjunctival MIGS stent Any of the above None of the above For presbyopic correction in my early/mild glaucoma patients, I use: Accommodative IOLs High add MFIOLs Low add MFIOLs EDOF IOLs Monovision None of the above